Astera Labs (NASDAQ:ALAB) Stock Price Down 7.5% - Here's Why

Key Points

• Shares fell 7.5% intraday to $166.15 from a prior close of $179.56, with about 2.68 million shares traded—roughly 30% below average daily volume.
• Analysts remain largely positive: the consensus rating is "Moderate Buy" with an average price target of $188.17 (1 Strong Buy, 15 Buy, 8 Hold).
• Fundamentals show strong growth—EPS of $0.49 beat the $0.39 estimate and revenue rose 103.9% YoY to $230.6M with Q4 2025 EPS guidance of $0.50–0.51—yet insiders sold about 576,936 shares (~$87.4M) in the past three months, including sizable CEO and CFO sales.

Astera Labs, Inc. (NASDAQ:ALAB - Get Free Report)'s stock price dropped 7.5% during mid-day trading on Monday . The company traded as low as $166.13 and last traded at $166.15. Approximately 2,679,115 shares were traded during trading, a decline of 30% from the average daily volume of 3,846,124 shares. The stock had previously closed at $179.56.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently issued reports on ALAB shares. Barclays reaffirmed an "equal weight" rating and set a $155.00 target price on shares of Astera Labs in a research report on Monday, October 20th. Citigroup reaffirmed an "outperform" rating on shares of Astera Labs in a research note on Tuesday, December 9th. Weiss Ratings reissued a "hold (c-)" rating on shares of Astera Labs in a research report on Wednesday, October 8th. BNP Paribas Exane started coverage on shares of Astera Labs in a research report on Thursday, November 20th. They issued an "outperform" rating and a $225.00 price target for the company. Finally, Cowen reaffirmed a "hold" rating on shares of Astera Labs in a research note on Wednesday, November 5th. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and eight have given a Hold rating to the company's stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $188.17.

Astera Labs Stock Performance

The firm has a market capitalization of $28.22 billion, a price-to-earnings ratio of 150.55, a price-to-earnings-growth ratio of 2.45 and a beta of 1.50. The business's 50 day moving average is $160.89 and its 200-day moving average is $161.33.

Astera Labs (NASDAQ:ALAB - Get Free Report) last announced its earnings results on Tuesday, November 4th. The company reported $0.49 earnings per share for the quarter, beating the consensus estimate of $0.39 by $0.10. Astera Labs had a return on equity of 13.48% and a net margin of 27.50%.The firm had revenue of $230.58 million during the quarter, compared to the consensus estimate of $206.42 million. During the same quarter in the prior year, the company earned $0.23 EPS. The firm's revenue for the quarter was up 103.9% compared to the same quarter last year. Astera Labs has set its Q4 2025 guidance at 0.50-0.510 EPS. Equities research analysts forecast that Astera Labs, Inc. will post 0.34 EPS for the current fiscal year.

Insider Buying and Selling at Astera Labs

In other Astera Labs news, CEO Jitendra Mohan sold 90,459 shares of the company's stock in a transaction dated Monday, November 17th. The shares were sold at an average price of $144.69, for a total transaction of $13,088,512.71. Following the transaction, the chief executive officer directly owned 2,080,418 shares in the company, valued at approximately $301,015,680.42. This represents a 4.17% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CFO Michael Truett Tate sold 11,430 shares of the stock in a transaction that occurred on Monday, November 17th. The shares were sold at an average price of $144.69, for a total transaction of $1,653,806.70. Following the completion of the transaction, the chief financial officer owned 192,297 shares in the company, valued at $27,823,452.93. This represents a 5.61% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 576,936 shares of company stock worth $87,409,540 over the last three months. 12.50% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Astera Labs

Several large investors have recently bought and sold shares of ALAB. Fred Alger Management LLC increased its position in shares of Astera Labs by 13.0% during the 1st quarter. Fred Alger Management LLC now owns 1,560,033 shares of the company's stock valued at $93,087,000 after purchasing an additional 179,638 shares during the last quarter. Hoey Investments Inc. increased its holdings in Astera Labs by 22.4% during the second quarter. Hoey Investments Inc. now owns 6,121 shares of the company's stock worth $553,000 after buying an additional 1,121 shares during the last quarter. Sumitomo Mitsui Trust Group Inc. increased its holdings in Astera Labs by 21.6% during the second quarter. Sumitomo Mitsui Trust Group Inc. now owns 14,781 shares of the company's stock worth $1,336,000 after buying an additional 2,624 shares during the last quarter. Wealth Effects LLC bought a new stake in Astera Labs in the second quarter worth about $242,000. Finally, Maryland State Retirement & Pension System boosted its stake in Astera Labs by 37.7% in the second quarter. Maryland State Retirement & Pension System now owns 6,960 shares of the company's stock valued at $629,000 after acquiring an additional 1,906 shares during the last quarter. Institutional investors own 60.47% of the company's stock.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company's product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.